Is this a piece of news regarding world politics, sports, business, or science and technology?
GenVec Shares Plunge on Study Halt GenVec Inc. shares lost almost half their value Thursday after the Food and Drug Administration halted a study of its lead product candidate because the anti-cancer drug may increase blood clots in patients. 
